Gwenn Hansen insider trades

Open-market stock purchases and sales by Gwenn Hansen, Chief Scientific Officer at Nurix Therapeutics, Inc, from SEC Form 4 filings since Nov 30, 2020.

Recent trades

DateStockTradeValue
Sep 1, 2026NRIX Nurix Therapeutics, IncSold$37K
Sep 1, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Aug 5, 2026NRIX Nurix Therapeutics, IncSold$109K
Aug 5, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Aug 4, 2026NRIX Nurix Therapeutics, IncSold$35.8K
Aug 4, 2026NRIX Nurix Therapeutics, IncSold$64.3K
Jul 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jul 30, 2026NRIX Nurix Therapeutics, IncSold$90K
Jul 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jul 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jun 25, 2026NRIX Nurix Therapeutics, IncSold$108K
Apr 30, 2026NRIX Nurix Therapeutics, IncSold$53.5K
Apr 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Apr 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Apr 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Feb 10, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Feb 10, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Feb 3, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncSold$79.5K
Jan 30, 2026NRIX Nurix Therapeutics, IncSold$1.7K
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Oct 30, 2025NRIX Nurix Therapeutics, IncBought (not open market)—

Companies traded

  • NRIX Nurix Therapeutics, Inc: 42 sales, last Sep 1, 2026

Get free alerts when Gwenn Hansen files a new trade →